Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
about
Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson's disease.Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners
P2860
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
@ast
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
@en
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
@nl
type
label
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
@ast
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
@en
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
@nl
prefLabel
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
@ast
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
@en
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
@nl
P2093
P2860
P3181
P356
P1476
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease
@en
P2093
Arvydas D Vanagunas
David A Johnson
E Roderich Gossen
Janet Benesh
Jordan Dubow
Krai Chatamra
Michael Epstein
Nathan Schmulewitz
Robert Hawes
Susan Eaton
P2860
P3181
P356
10.1038/CTG.2016.19
P407
P577
2016-01-01T00:00:00Z